Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins

Immunology

Volumn 90, Issue 4, 1997, Pages 526-533

  De Sanctis, J B ^a,b   Blanca, I ^a   Bianco, N E ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Instituto de Inmunologia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030950219     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00174.x     Document Type: Article

References (23)

1. ROSS R. (1993) The pathogenesis of atherosclerosis: a perspective fo the 1990s. Nature 326, 801.
2. TRAILL K.N., HUBER L.A., WICK G. & JURGENS G. (1990) Lipoprotein interactions with T cells, an update. Immunol Today 11, 411.
3. KRIGER M. & HERTZ J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor related protein (LRP). Ann Rev Biochem 63, 601.
4. ENDEMANN G., STANTON L.W., MADDEN K.S., BRYANT C.M., WHITE R.T. & POTTER A.A. (1993) CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268, 11811.
5. ALAM R., YATSU F.M., TSUI L. & ALAM S. (1989) Receptor-mediated uptake and 'retroendocytosis' of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport. Biochim Biochim Acta 1004, 292.
6. STANTON L.W., WHITE R.T., BRYANT C.M., PROTTER A.A. & ENDEMANN G. (1992) A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem 267, 22446.
7. SMITH K.A. (1992) Interleukin 2. Curr Opin Immunol 4, 271.
8. WHITESIDE T.L. & HERBERMAN R.B. (1994) Role of human killer cells in health and disease. Clin Diagn Lab Immunol 1, 125.
9. TRINCHIERI G. (1989) The biology of NK cells. Adv Immunol 47, 187.
10. DE SANCTIS J.B., BLANCA I. & BIANCO N.E. (1995) Effects of lipoproteins on the proliferative response of interleukin 2 activated T and large granular lymphocytes Clin Sci 89, 511.
11. + cells: Effect of interleukin 2. Cell Immunol 167, 18.
12. DE SANCTIS J.B., BLANCA I. & BIANCO N.E. (1995) Expression of different lipoprotein receptors in NK cells and their effect on NK proliferative and cytotoxic activity. Immunology 86, 399.
13. HAVEL R.J., EDER H.H. & BRAGDON J.H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34, 1435.
14. EL-SAADANI M., ESTERBAUER H., EL-SAYED M., GOHER M., NASSAR A.Y. & JÜRGENS G. (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30, 627.
15. BASU S.K., GOLDSTEIN J.L., ANDERSON R.G.W. & BROWN M.S. (1976) Degradation of cataionized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 73, 3178.
16. DE SANCTIS J.B., BLANCA I., RADZIOCH D. & BIANCO N.E. (1994) Lipoprotein lipase expression in natural killer cells and its role in their cytotoxic activity. Immunology 83, 232.
17. MCCARTHY B.M., OKANO Y., NAKAYASU T., MACY M., WATSON S.R. & HARMONY J.A.K. (1987) Plasma lipoprotein and transferin regulate the proliferative response of a continuous T lymphocyte cell line. J Lipid Res 28, 1067.
18. NAUME B. & ESPEVIK T. (1994) Immunoregulatory effects of cytokines on natural killer cells. Scand J Immunol 40, 128.
19. YOKOTA T. & HANSSON G.K. (1995) Immunological mechanisms in ahterosclerosis. J Int Med 238, 479.
20. GENG Y.J. & HANSON G.K. (1992) Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 89, 1322.
21. MARSHALL M.K., DOERRLER W., FEINGOLD K.R. & GRUNFELD C. (1994) Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 135, 141.
22. KATZNELSON S., KOBASHIGAWA J.A., WANG X.M. et al. (1994) Pravastatin use in heart transplant patients suppresses natural killer cell (NKC) cytotoxicity and may be associated with reduced allocraft rejection. Circulation 90, A1072.
23. LIBBY P. (1992) Do vascular cytokines promote atherosclerosis? Hospital Practice 27, 51.